We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Nasal Bacteria Could Predict Skin Infections

By LabMedica International staff writers
Posted on 05 Jun 2014
Print article
Image: Scanning electron micrograph of Methicillin-resistant Staphylococcus aureus and a dead human neutrophil (Photo courtesy of the US National Institute of Allergy and Infectious Diseases).
Image: Scanning electron micrograph of Methicillin-resistant Staphylococcus aureus and a dead human neutrophil (Photo courtesy of the US National Institute of Allergy and Infectious Diseases).
Bacteria found in the nose may be a key indicator for future development of skin and soft-tissue infections in remote areas of the body.

The nose is the primary reservoir of Staphylococcus aureus in humans and in nearly 80% of the cases, an individual's colonizing strain is the same strain that causes subsequent remote skin infections. However, until now, no one has been able to determine why some S. aureus carriers develop infections while others do not.

Scientist at the Uniformed Services University of the Health Sciences (Bethesda, MD, USA) postulated that the population of S. aureus in an individual's nose may harbor valuable clues regarding skin and soft tissue infections (SSTI) susceptibility that had not yet been described. This is of particular interest to the military, as it is well known that soldiers in training are at increased risk of developing an SSTI. They collected nasal samples and cultures from 86 infantry soldiers and for those individuals among the 86 who developed SSTIs, the investigators also collected samples and cultures from within the soldiers' skin abscesses.

The team used a high-throughput DNA sequencing strategy to determine the microbial composition of each sample. The biodiversity of the bacterial population in each nose was compared between individuals colonized and/or infected with Methicillin-Resistant S. aureus (MRSA), Methicillin-Sensitive S. aureus (MSSA), and those individuals that were culture-negative for S. aureus.

The scientists observed a significantly higher percentage of a type of bacteria known as Proteobacteria in the noses of individuals who did not develop SSTI, suggesting that Proteobacteria may, in fact, be protective against the development of SSTIs. Furthermore, S. aureus carriers had a unique nasal microbiome that differed from non-carriers. The Proteobacteria are a major phylum of bacteria. They include a wide variety of pathogens, such as Escherichia, Salmonella, Vibrio, Helicobacter, and many other notable genera.

The scientists concluded that by establishing a nose marker microbiome associated with development of SSTI infections may pave the way for focused preventive treatments that target the microbiome, rather than S. aureus itself. They believe that this study will aid in the design of future prophylactic procedures that can help prevent SSTI, particularly in the setting of military training, and help influence how health care providers think about and treat these complex and diverse infections. The study was presented at the 114th General Meeting of the American Society for Microbiology held May 17–20, 2014, in Boston (MA, USA).

Related Links:

Uniformed Services University of the Health Sciences


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: AI analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer (Photo courtesy of Adobe Stock)

Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer

Ovarian cancer is one of the most common causes of cancer deaths among women and has a five-year survival rate of around 50%. The disease is particularly lethal because it often doesn't cause symptoms... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Pathology

view channel
Image: The device can serve as a sample pretreatment tool for cytological diagnosis of malignant effusions (Photo courtesy of Microsystems & Nanoengineering: Zhu, Z., Ren, H., Wu, D. et al.)

Microfluidic Device for Cancer Detection Precisely Separates Tumor Entities

Tumor cell clusters are increasingly recognized as crucial in cancer pathophysiology, with growing evidence of their increased resistance to treatment and higher metastatic potential compared to single tumor cells.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.